Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1983-09-23
1985-12-24
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
560121, C07C 69732, C07C 69738, A61K 31215
Patent
active
045607036
ABSTRACT:
Novel clavulone derivatives of the formula: ##STR1## wherein R.sup.1 and R.sup.2 combine together to form a keto group or either one of R.sup.1 and R.sup.2 is hydrogen atom and another one of them is hydroxy or acetoxy group, R.sup.3 and R.sup.4 are the same or different and are each hydrogen atom or acetoxy group, n is 0 or 1, provided that when the C--C bond between 8 and 12 positions is double bond, n is 0, a, b, c, d and e are each an integer of 1 or 2, and the dotted line means that the C--C bond is a single bond or double bond, or a salt thereof, which have excellent anti-inflammatory activity and anti-tumor activity and hence are useful as an anti-inflammatory agent or anti-tumor agent.
REFERENCES:
Iguchi et al., Tet. Letters, 24(41) 4433 (1983).
K. Kuchi et al., Tet. Letters 23(49) 5171 (1982).
Kobayashi et al., Tet. Letters 23(50) 5331 (1982).
Fukushima Masanori
Hirai Osamu
Kikuchi Hiroyuki
Manda Toshitaka
Shimizu Iwao
Fujisawa Pharmaceutical Co. Ltd.
Gerstl Robert
LandOfFree
Clavulone derivatives, process for preparing the same, and use o does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Clavulone derivatives, process for preparing the same, and use o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clavulone derivatives, process for preparing the same, and use o will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1479570